Larry Z. Liu - Concepedia

Author

Larry Z. Liu

Pfizer (United States)

Also Known As

Bosworth, Hayden B., Larry Z Liu, Larry Z. Liu

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Cornell University Division of Cancer Epidemiology and Genetics Johns Hopkins University United States Department of Health and Human Services

About

Larry Z. Liu is an author at Pfizer (United States) specializing in medicine, public health, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.4K
2	Public Health	10	10	1.3K
3	Environmental Health	4	4	244
4	Health Sciences	2	2	87
5	Diabetes	1	1	30

Larry Z. Liu

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Epidemiology and Outcomes of Health-care–Associated Pneumonia Marin H. Kollef, Andrew F. Shorr, Ying P. Tabak, CHEST Journal Pulmonary CareHealth-care–associated PneumoniaClinical EpidemiologyRespiratory InfectionInfectious Respiratory Disease	2005	945
Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database* Andrew F. Shorr, Ying P. Tabak, Aaron Killian, Critical Care Medicine	2006	283
Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia Andrew F. Shorr, Ying P. Tabak, Vikas Gupta, Critical Care	2006	159
Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China Warren Stevens, Desi Peneva, Jim Z. Li, BMC Health Services Research	2016	106
Variation in lung cancer risk by smoky coal subtype in Xuanwei, China Qing Lan, Xingzhou He, Linwei Tian, International Journal of Cancer Smoky Coal SubtypeEpidemiology Of CancerPathologyLung Cancer RiskLung Cancer Rates	2008	101
Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups Gregory Y.H. Lip, Stephen Mitchell, Xianchen Liu, International Journal of Cardiology ThrombosisVenous ThrombosisCardiovascular DiseaseNon-valvular Atrial FibrillationRelative Efficacy	2015	84
Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Gregory Y.H. Lip, Thitima Kongnakorn, Hemant Phatak, Clinical Therapeutics	2014	83
Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting Robert J. Straka, Larry Z. Liu, Prafulla S Girase, Cardiovascular Diabetology	2009	81
Smoky coal, tobacco smoking, and lung cancer risk in Xuanwei, China Christopher Kim, Robert S. Chapman, Wei Hu, Lung Cancer Tobacco ControlSmoky CoalTobacco UseGlobal HealthEnvironmental Health	2014	61
Pharmacoeconomics Impact of Linezolid on Economic Outcomes and Determinants of Cost in a Clinical Trial Evaluating Patients with MRSA Complicated Skin and Soft-Tissue Infections Peggy S. McKinnon, Sonja Sorensen, Larry Z. Liu, Annals of Pharmacotherapy	2006	58

Page 1